Request for an Advisory Opinion — Compliance with USP <797> Cannot Constitute Insanitary Conditions for Section 503A Sterile Compounding Pharmacies | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-A-1891

Request for an Advisory Opinion — Compliance with USP <797> Cannot Constitute Insanitary Conditions for Section 503A Sterile Compounding Pharmacies

Documents

Comments

Description

Open

Key Dates

Comment Period OpensFeb 20, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Advisory Opinion Request from Pistevo Law LLC	Feb 20, 2026	--

Keywords

CDER

Pistevo Law LLC

Request for an Advisory Opinion

Compliance with USP <797> Cannot Constitute

Insanitary Conditions for Section 503A

Sterile Compounding Pharmacies

Open

Data from Regulations.gov